Publication | Closed Access

Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients

Tumor BiologyBreast OncologyOncologyClinical ResistanceMedicineImmune Checkpoint InhibitorExtracellular MicrovesiclesBreast CancerPlasma-derived ExosomesCell BiologyCdk4/6 InhibitorsCancer TreatmentCancer BiologyRadiation OncologyExosomes